h-Relaxin 3A / h Relaxin 2B
$467.00
- Mass / Quantity: 100 µg
- Catalog #: 036-23
- Form & Storage: Lyophilized powder | Store desiccated at -20°C
🔥 Exclusive Crypto Offer
Get an INSTANT 15% DISCOUNT when you pay with Bitcoin, Ethereum, Dogecoin, Bitcoin Cash, XRP, Solana, or USDT.
⚡ Don't have crypto? Buy it here in 5 minutes with easy guidance.
💡 Pro Tip: You can also pay with cryptocurrency using your verified Cash App or PayPal account for a fast and secure checkout!
h-Relaxin 3A / h Relaxin 2B
The h-Relaxin 3A / h Relaxin 2B (Catalog #036-23) is a research reagent supplied by Phoenix Peptide under our specialized Peptides category. This item is offered at a regular price of $467 for a package size of 100 µg.
Related Research Products & Support
For complementary laboratory workflows, explore related items in our catalog: ACTH (1-24) (Human, Rat, Mouse, Porcine), AcSDKP, and AcPHF6 / Ac-Tau (623-628) available through Phoenix Peptide. Guaranteed for quality assurance and analytical precision.
| Specification / Feature | Details |
|---|---|
| Catalog Number | 036-23 |
| Mass / Quantity | 100 µg |
| Category | Peptides |
| Price / Unit | $467 |
| Sequence: | Asp-Val-Leu-Ala-Gly-Leu-Ser-Ser-Ser-Cys-Cys-Lys-Trp-Gly-Cys-Ser-Lys-Ser-Glu-Ile-Ser-Ser-Leu-Cys |
| B-Chain: | Asp-Ser-Trp-Met-Glu-Glu-Val-Ile-Lys-Leu-Cys-Gly-Arg-Glu-Leu-Val-Arg-Ala-Gln-Ile-Ala-Ile-Cys-Gly-Met-Ser-Thr-Trp-Ser |
| Molecular Weight: | 5770.7 |
| Validation: | Exhibits correct molecular weight |
| Storage: | Up to 6 months in lyophilized form at 0-5°C. For best results, rehydrate just before use. After rehydration, keep solution at +4°C for up to 5 days or freeze at -20°C for up to 3 months. Aliquot before freezing to avoid repeated freeze-thaw cycles. |
| Appearance: | White powder |
| Contents: | Each vial contains 100 µg of NET peptide. |
| Disulfide Bridge: | Disulfide bridge(s): CysA10-CysA15, CysA11-CysB11, CysA24-CysB23 |
Only logged in customers who have purchased this product may leave a review.
Related products
Reviews
There are no reviews yet.